Patent · US Active

Human monoclonal antibodies to Staphylococcus aureus lukab toxin

US10981979B2 · kind B2 · utility

0Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2018
Grant dateApr 20, 2021
Priority date—
Expiry dateMar 6, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to antibodies binding to prefusion and postfusion forms of both human S. aureus and human metapneumovirus F proteins, including neutralizing antibodies, and methods for use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.